In Memoriam  Robert Ellis Shope  1929–2004 by Murphy, Frederick A. et al.
IN MEMORIAM
Robert Ellis Shope
1929–2004
R
obert Ellis Shope, one of the
world’s most distinguished
arbovirologists and a dear friend of
many colleagues around the world,
died of complications of idiopathic
pulmonary fibrosis in Galveston,
Texas, on January 19, 2004, at age 74.
Bob is survived by his wife, Virginia;
his daughters, Deborah Shope and
Bonnie (Shope) Rice; his sons, Peter
and Steve; his brothers, Thomas and
Richard; his sister, Nancy (Shope)
FitzGerrell; and six grandchildren.
It is difficult to describe Bob’s
many contributions to virology, epi-
demiology, tropical medicine, infec-
tious disease sciences, vector biology,
and international public health
because they are so numerous and
varied. His lifelong contributions to
our understanding of arthropod-borne
viruses, hemorrhagic fever viruses,
and the diseases these viruses cause
are without equal. He discovered and
characterized more previously
unknown viruses than any other per-
son in history. Working at various
times in nearly every country where
these viruses and diseases are impor-
tant, he collaborated with virtually
everyone who has worked in these
fields in the past 50 years. Until his
death, he remained an international
leader in framing the global response
to emerging and reemerging diseases
and our national response to bioterror-
ism, while at the same time keeping
his own laboratory productive—his
research was funded continuously by
the National Institutes of Health
(NIH) for 26 years.
Arguably, Bob’s most important
contribution was his co-chairing,
along with Joshua Lederberg and
Stanley Oaks, of the Institute of
Medicine Committee on Emerging
Microbial Threats to Health. The pro-
ceedings of this committee led to the
publication in 1992 of Emerging
Infections: Microbial Threats to
Health in the United States (National
Academy Press). This seminal publi-
cation, which outlined factors impli-
cated in the emergence of infectious
diseases and the programs and
resources needed to cope with them,
initiated much of the current world-
wide interest in infectious diseases.
He then spent endless days explaining
the concepts underpinning the report
in order to gain public and political
support. His efforts were marked by
great success, as evidenced by the
revitalized state of the infectious dis-
ease sciences today. 
Bob was born in Princeton, New
Jersey, the son of Richard Shope, an
internationally renowned virologist.
He received BAand MD degrees from
Cornell University and completed an
internship in internal medicine at
Grace-New Haven Hospital (Yale
University School of Medicine). He
then spent 3 years in the U.S. Army
Medical Corps, where he was initially
assigned to Camp Detrick (now the
U.S. Army Medical Research Institute
for Infectious Diseases) and later to
the U.S. Army Medical Research Unit
in Kuala Lumpur. The latter experi-
ence, involving studies on the etiolo-
gy of fevers of unknown origin among
British soldiers and the local
Malaysian civilian population, had a
profound effect on his subsequent
research interests and career deci-
sions. After starting a residency in
internal medicine at Yale, he left to
take a staff position with the
Rockefeller Foundation’s Inter-
national Virus Program in its laborato-
ry in Belem, Brazil (now the Instituto
Evandro Chagas). There he remained
for 6 years, eventually serving as
director of that institute. This was a
time of great excitement and discov-
ery, as many new viruses were being
isolated and characterized. In 1965,
Bob returned from Brazil to Yale,
where most of the senior staff of the
Rockefeller Foundation’s overseas
virus program had relocated and were
establishing the Yale Arbovirus
Research Unit (YARU). Bob
remained at Yale for 30 years, rising
to the rank of professor and director of
that research unit. 
In 1995, Bob moved to the
University of Texas Medical Branch
in Galveston, where he held several
appointments: professor (Department
of Pathology, Department of
Microbiology and Immunology,
Department of Preventive Medicine
and Community Health), associate
director of the university’s Center for
Biodefense (and John S. Dunn
Distinguished Chair in Biodefense),
and member (Sealy Center for
Environmental Health & Medicine,
Sealy Center for Structural Biology,
and World Health Organization
[WHO] Collaborating Center for
Tropical Diseases). 
At various times throughout his
long career, Bob served as president
and councilor, American Society of
Tropical Medicine and Hygiene; chair
and member, Advisory Council,
James A. Baker Institute for Animal
Health, Cornell University; member,
WHO Expert Panel on Virus Diseases,
and member U.S. Delegation to the
U.S.–Japan Cooperative Medical
Science Program, International
Committee on Taxonomy of Viruses
(ICTV), Armed Forces Epidemiology
Board, Advisory Board  of the Fogarty
International Center, National
Institutes of Health, Institute of
Medicine Committee on Improving
Civilian Medical Response to
Chemical and Biological Terrorism
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Incidents, Advisory Committee
(American Museum of Natural
History Infectious Disease Exhi-
bition), Advisory Panel (National
Research Council Program on
Strategies to Protect the Health of
Deployed U.S. Forces), and the
National Research Council
Committee on Climate, Ecosystems,
Infectious Diseases, and Human
Health.
Over the years, Bob earned many
honors, including the Bailey K.
Ashford Award from the American
Society of Tropical Medicine and
Hygiene, the Richard M. Taylor
Award from the American Committee
of Arthropod-Borne Viruses, and the
Walter Reed Medal from the
American Society of Tropical
Medicine and Hygiene.
In November 2003, the University
of Texas Medical Branch celebrated
the completion of a biosafety level 4
laboratory, the first in the United
States at an academic institution. In
Bob’s honor, the laboratory was
named “The Robert E. Shope, M.D.
Laboratory.” Also in his honor, the
university established the Robert E.
Shope, M.D. Memorial Fellowship in
emerging viral diseases research.
Professional Odyssey
Bob’s first assignment with the
Rockefeller Foundation in New York
in 1954 was to study the etiology of
“epidemic polyarthritis,” a disease
characterized by fever, arthralgia, and
rash that occurred mainly during the
summer in coastal regions of
Australia. In a classic retrospective
serologic investigation, he and S.G.
Anderson demonstrated that the dis-
ease was caused by an alphavirus. Ten
years later, Australian scientists, led
by Ralph Doherty and Ian Marshall,
isolated Ross River virus and con-
firmed its association with epidemic
polyarthritis. 
In the early 1960s, during Bob’s
tenure at what is now the Instituto
Evandro Chagas, he isolated and char-
acterized more than 50 tropical
arboviruses, most of which were new
to science. Several, such as group C
and Guama viruses, caused human
disease. Not only did he play a role in
isolating and characterizing these
agents and their diseases, but his team
was instrumental in studying and
understanding the role of their forest
reservoirs. He refined the capture-
mark-release-recapture technology
for rodents, marsupials, and birds, and
applied these methods to the Amazon
fauna. His team also correlated verte-
brate reservoir ecology with that of
vector mosquitoes. He identified
Oropouche virus when the first epi-
demic struck the city of Belem. This
disease has since emerged as a major
scourge, not only in the Brazilian
Amazon, but also in cities in Panama
and Peru. 
During his early tenure at the Yale
Arbovirus Research Unit, Bob was
involved in a collaborative project
with the Smithsonian Institution and
discovered several new arboviruses
transported by birds migrating
through the Nile Delta. Then, in 1969,
Lassa fever and yellow fever emerged
in Nigeria and occupied his research
for several years. 
Bob was first to show that rabies
virus was related to other viruses (the
“rabies-related viruses”); in 1970,
with Fred Murphy and others, he
characterized Mokola, Lagos bat, and
Duvenhage viruses, the founding
members (along with rabies virus) of
the genus Lyssavirus, family
Rhabdoviridae. In 1971, Bob, Fred
Murphy, and Ernie Borden character-
ized many bluetongue-like viruses
and established the genus Orbivirus,
family  Reoviridae. In 1971, Bob
coauthored an obscure paper in the
Indian Journal of Medical Research
describing Thottapalayam virus, a
presumed arbovirus isolated from a
shrew in India. Thottapalayam virus
was subsequently shown to be a han-
tavirus, the first hantavirus to be iso-
lated (Hantaan virus, the type virus of
the genus Hantavirus,  family
Bunyaviridae, was not isolated until
1976). 
In 1977, Bob identified a virus iso-
lated from a mixed pool of midges
(culicoids) collected near Darwin,
Australia, and sent to him by Toby St.
George. Bob identified it as blue-
tongue 20 virus, the first bluetongue
virus recognized in Australia. This
discovery caused economic turmoil in
the Australian livestock industry, but
it was seminal in initiating an inten-
sive research program in that country.
That same year, Bob and Jim Meegan
identified Rift Valley fever virus as
the cause of a “virgin soil” epidemic
in Egypt that affected 200,000 people,
with more than 600 human deaths,
and hundreds of thousands of sheep
and cattle deaths. Also noteworthy is
that in 1977, Bob co-authored the first
description of Lyme disease in the
United States. This work was done
with Allan Steere, then a young
rheumatologist at Yale. Lyme disease
was subsequently recognized as the
most important tick-borne disease in
North America.
Throughout the most recent 20
years, Bob and his colleagues, espe-
cially Bob Tesh, continued to discov-
er new, important viruses. These
included Sabiá, the cause of Brazilian
hemorrhagic fever, and Guanarito, the
cause of Venezuelan hemorrhagic
fever. Bob also worked to develop an
attenuated-live virus vaccine for
dengue and chaired the WHO adviso-
ry committee on dengue vaccine
development. 
After moving to the University of
Texas Medical Branch in 1995, Bob
embarked on a new phase of his
career; he and his colleagues initiated
a new program on bioterrorism coun-
termeasures, centered on novel antivi-
ral drugs against alphavirus, fla-
vivirus, and arenavirus diseases. At
the same time, along with Bob Tesh,
Bob brought the World Reference
Center for Emerging Viruses and
Arboviruses to the university—this is
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one of the most valuable virus collec-
tions in the world, comprising >4,000
arthropod-borne virus strains and
>1,000 other virus strains.
Scientific Legacy
In addition to the many scientific
contributions already mentioned, Bob
wrote and edited more than 170 refer-
eed papers and more than 90 books,
chapters, and monographs. Most
notable of his editorial activities was
his contribution to several editions of
the definitive reference book in virol-
ogy, Fields Virology (Bernard N.
Fields, editor; David Knipe, Robert
Chanock, Joseph Melnick, Bernard
Roizman, Robert Shope, Martin
Hirsch, Thomas Monath, Peter
Howley, and Stephen Straus, co-edi-
tors; Lippincott Williams & Wilkins). 
Bob’s oral contributions are
legion. Over the years, he presented
many hundreds of seminars, lectures,
and workshops throughout the world,
but he never kept track of them. One
can only guess at the numbers, but it
is easy to recall their overall impact in
many disciplines of medical science.
Legacy as a National 
and International Advisor 
and Consultant
Bob served the national and inter-
national interests of science in many
ways—he was an outstanding
spokesman, always willing to take
extra time and effort to “educate”
politicians and science leaders. He did
this at an ever-higher level of impact:
in 1997 Bob was invited to the White
House along with six other scientists,
three of them Nobel laureates, to brief
President Bill Clinton, Vice President
Al Gore, and others on the perils of
global warming and its importance in
the spread of infectious agents, such
as those causing dengue and dengue
hemorrhagic fever, malaria, and many
other arthropod-borne diseases. 
Bob served as consultant and advi-
sor to many national and international
organizations. Throughout his career
he was a frequent advisor to the NIH,
Centers for Disease Control and
Prevention, Department of Defense,
U.S. Department of Agriculture, U.S.
Agency for International Develop-
ment, the Institute of Medicine, and
the American Type Culture
Collection. He was also a frequent
consultant to WHO and the Pan
American Health Organization, as
well as to foreign governments. 
Legacy as a Teacher 
and Mentor
Bob was an outstanding, devoted,
and beloved teacher. He cared deeply
about the next generation of profes-
sionals entering the various fields of
the clinical infectious disease sci-
ences, virology, vector biology, epi-
demiology, and public health. His
honesty, humility, enthusiasm, and
caring manner endeared him to his
students. He treated everyone with
respect and was never too busy to
meet with a student or to offer guid-
ance. But there was more; there was a
kind of magic in his “touch” as
teacher and mentor. For example, Bob
participated for many years in the
Cornell Summer Leadership Program,
run lovingly by Doug McGregor. At
the end of a day spent in workshops,
the students would gather in a lounge
for a beer and informal discussion
with the faculty. Within minutes, other
guest faculty members were forgotten
as the students zeroed in on Bob—
they instinctively knew that he was
the utmost rolemodel, an inspiration
in deciding career directions. 
Legacy as a Colleague 
and Friend
Over the years, Bob worked with
many prominent arbovirologists and
vector biologists, including, in his
tenure at Yale, Tommy Aitken, John
Anderson, Sonia Buckley, Jordi
Casals, Delphine Clarke, Wilbur
Downs, Max Theiler, Loring
Whitman, Jack Woodall, Barry Beaty,
Rebecca Rico-Hesse, Dennis
Knudson, Barry Miller, Thomas
Schwann, Thomas Scott, Mark
Wilson, and others. During his tenure
at the University of Texas Medical
Branch, he worked closely with Dave
Walker, Bob Tesh, C.J. Peters, Stan
Lemon, Scott Weaver, Alan Barrett,
Judith Aronson, Chuck Fulhorst,
Norb Herzog, Steve Higgs, Peter
Mason, Doug Watts, Larry Stanberry,
and others. But, such lists are folly—
Bob’s true legacy as a colleague and
friend would require a list of hun-
dreds of names, from across the years
and around the world. It would be
wonderful to append such a list here,
but it would be suspect in its likely
omissions. 
The essence of Bob’s legacy as a
colleague and friend is the most diffi-
cult matter to capture here. After his
death, condolences to his colleagues
and family contained oft-repeated
themes:
“He was the nicest, humblest, most
self-effacing, and obliging person I
have ever known…”
“He was unfailingly kind and gen-
erous…”
“He was always collegial with col-
laborators and endlessly patient with
students; it is not surprising that he
earned both the respect and love of
both…”
“He consistently exemplified and
fostered an attitude of service…”
“He always made time for you,
whether you were a student or the
minister of health…”
“He was always reassuring, upbeat
and helpful…”
“He was an exceptionally gener-
ous person, and that tended to rub off
on others…”
“His enthusiasm and love for his
chosen field were as infectious as the
viruses he studied…”
“Those of us who knew him and
worked with him were very fortu-
nate…”
“He was a catalyst of honesty, pro-
fessionalism, and mutual respect….”
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“We all benefited from his exam-
ple…”
“He was the best listener in the
world…”
“He always acted in the best inter-
ests of others, truly practicing the
golden rule of treating others as he
would wish to be treated…”
“We were blessed to have had him
as a colleague...”
Running through these messages is
the understanding that the field of
arbovirology and related sciences has
been incredibly satisfying to the
involved community because of the
warmth of personal relationships and
the high ethical standard shared by
one and all. In these messages, it is
clear that everyone knew that Bob
was the “keeper of the flame,” the
exemplar, the strong positive influ-
ence on everyone in this community.
This was not a passive matter—in the
most subtle way Bob vaccinated oth-
ers with his high ethical standard—
magic, again!
The messages received in
Galveston upon Bob’s death capture
another theme, one based in each per-
son’s memories of his or her earliest
days in the world of medical research
and public service. It seems that
many, many people have a clear mem-
ory of their first experience with Bob.
Two messages, anonymously para-
phrased here, are exemplary. First,
“…In the 1970s I went to YARU with
a few viruses that had been brought
back from Kenya and couldn’t be
identified. I was new to the field and
had little clue how to go about deter-
mining what these viruses were. But I
had landed in the World Reference
Center! Bob took me under his wing.
He showed me the reference collec-
tion, inventoried on a huge Rolodex.
We talked about the possibilities
based on the source of the unknown
viruses. Bob stayed with me until 10
p.m. developing a testing plan, and
then drove me to my hotel. My head
was spinning. YARU was a busy place
and there were many other much more
important visitors, but Bob worked
closely with me over the week until
we had identified all of the viruses.
The result was one of my first publi-
cations in arbovirology…”
Second, “…I well remember as a
young nobody from the outback of
Africa arriving to consult with Bob at
YARU in 1975. I wanted some refer-
ence arbovirus reagents to take home
with me, and having just met me, Bob
worked with me late into the evening,
freeze-drying viruses and antigens so
that I could leave with them on the
following day…” 
Does all this capture Bob Shope,
the man, the friend that we have lost?
If not, then words cannot serve what
memories can. To say that Bob will be
missed is the greatest of understate-
ments—he will never be forgotten. He
leaves to us a legacy of enthusiastic
commitment to his science and an
equal commitment to the application
of that science for the benefit of the
people of the world. As well, he
leaves to us, by the example of his
life, a definition of our sense of com-
munity and the keys to its nurturing.
Respectfully submitted on behalf of
the world’s community of virologists,
especially the community of arbovirolo-
gists,
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